BAB, Inc.
BABB
$0.7788
$0.02873.83%
| Weiss Ratings | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.32 | |||
| Price History | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.69% | |||
| 30-Day Total Return | 0.56% | |||
| 60-Day Total Return | 4.17% | |||
| 90-Day Total Return | 3.93% | |||
| Year to Date Total Return | 4.53% | |||
| 1-Year Total Return | 4.86% | |||
| 2-Year Total Return | -13.09% | |||
| 3-Year Total Return | 4.64% | |||
| 5-Year Total Return | -4.34% | |||
| 52-Week High % Change | -8.38% | |||
| 52-Week Low % Change | 16.24% | |||
| Price | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.85 | |||
| 52-Week Low Price | $0.67 | |||
| 52-Week Low Price (Date) | Mar 26, 2024 | |||
| 52-Week High Price (Date) | Jul 07, 2023 | |||
| Valuation | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.66M | |||
| Enterprise Value | 4.18M | |||
| Price/Earnings (TTM) | 10.65 | |||
| Earnings Per Share (TTM) | 0.07 | |||
| Earnings Per Share Growth | 31.24% | |||
| Price/Earnings To Growth | 0.34 | |||
| Price/Sales (TTM) | 1.57 | |||
| Price/Book (Q) | 1.81 | |||
| Enterprise Value/Revenue (TTM) | 1.16 | |||
| Price | $0.78 | |||
| Enterprise Value/EBITDA (TTM) | 6.04 | |||
| Enterprise Value/EBIT | 6.08 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 7.26M | |||
| Dividend Yield | 5.14% | |||
| Div. Per Share (Most Recent) | $0.01 | |||
| Dividend Per Share (TTM) | $0.04 | |||
| Payout Ratio (TTM) | 82.15% | |||
| Dividend Per Share (Most Recent) | $0.01 | |||
| Company Info | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 847 948 7520 | |||
| Address | 500 Lake Cook Road Deerfield, IL 60015 | |||
| Website | www.babcorp.com | |||
| Country | United States | |||
| Year Founded | 1993 | |||
| Profitability | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 19.09% | |||
| Profit Margin | 14.73% | |||
| Management Effectiveness | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 9.54% | |||
| Return on Equity | 17.40% | |||
| Income Statement | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.60M | |||
| Total Revenue (TTM) | 3.60M | |||
| Revenue Per Share | $0.50 | |||
| Gross Profit (TTM) | 2.33M | |||
| EBITDA (TTM) | 691.30K | |||
| EBIT (TTM) | 687.40K | |||
| Net Income (TTM) | 530.50K | |||
| Net Income Avl. to Common (TTM) | 530.50K | |||
| Total Revenue Growth (Q YOY) | 12.11% | |||
| Earnings Growth (Q YOY) | 179.04% | |||
| EPS Diluted (TTM) | 0.07 | |||
| EPS Diluted Growth (Q YOY) | 177.55% | |||
| Balance Sheet | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.89M | |||
| Cash Per Share (Q) | $0.26 | |||
| Total Current Assets (Q) | 2.30M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.13M | |||
| Current Ratio (Q) | 2.975 | |||
| Book Value Per Share (Q) | $0.43 | |||
| Total Assets (Q) | 4.71M | |||
| Total Current Liabilities (Q) | 774.20K | |||
| Total Debt (Q) | 411.40K | |||
| Total Liabilities (Q) | 1.58M | |||
| Total Common Equity (Q) | 3.13M | |||
| Cash Flow | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.20K | |||
| Cash from Financing (TTM) | -363.10K | |||
| Net Change in Cash (TTM) | 182.40K | |||
| Levered Free Cash Flow (TTM) | 550.90K | |||
| Cash from Operations (TTM) | 546.70K | |||
